Observational studyClinical journal of the American Society of Nephrology : CJASN2019
Patients,' Nephrologists,' and Predicted Estimations of ESKD Risk Compared with 2-Year Incidence of ESKD.
Observational study in Clinical journal of the American Society of Nephrology : CJASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 50 citations in OpenAlex.
- External validation, recalibration, and clinical utility of the kidney failure risk equation in patients with advanced CKD: a nationwide retrospective cohort analysis in Peru.BMC nephrology · 2025Article
- Risk-directed management of chronic kidney disease.Nature reviews. Nephrology · 2025Review
- Estimates of eskd risk and timely kidney replacement therapy education.BMC nephrology · 2024Observational
- External validation of the KFRE and Grams prediction models for kidney failure and death in a Spanish cohort of patients with advanced chronic kidney disease.Journal of nephrology · 2024Article
- Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making.Clinical kidney journal · 2024Article
- Article
- Article
- Implementation of the Kidney Failure Risk Equation in a United States Nephrology Clinic.Kidney international reports · 2023Article
- Predicting outcomes in chronic kidney disease: needs and preferences of patients and nephrologists.BMC nephrology · 2023Article
- Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.Kidney medicine · 2022Article
- Patient Perspectives on Integrating Risk Prediction Into Kidney Care: Opinion Piece.Canadian journal of kidney health and disease · 2022Article
- Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis.The Permanente journal · 2021Article
- A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.BMC nephrology · 2021Article
- Medical Record Documentation of Goals-of-Care Discussions Among Older Veterans With Incident Kidney Failure.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
BACKGROUND AND
objectivesThe rate of progression to ESKD is variable, and prognostic information helps patients and physicians plan for future ESKD. We assessed the estimations of ESKD risk of patients with CKD and physicians and compared them with risk calculators and outcomes at 2 years. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective observational study assessed 257 adult patients with CKD stages 3-5 and their nephrologists at University of California, San Diego and Veterans Affairs San Diego CKD clinics. Patients' and nephrologists' estimations of 2-year ESKD risk were evaluated, and objective estimation of 2-year risk was determined using kidney failure risk equations; actual incidence rates of ESKD and death were ascertained by chart review. Participants' baseline characteristics were compared across kidney failure risk equation risk levels and according to whether patients' estimations were more optimistic or pessimistic than physicians' estimations. We examined correlations between estimations and compared estimations with outcomes using
resultsAverage age was 65 (±13) years old, and eGFR was 34 (±13) ml/min per 1.73 m
conclusionsCompared with actual ESKD incidence, the kidney failure risk equation outperformed patients' and physicians' estimations of ESKD incidence. Patients and physicians overestimated risk compared with the kidney failure risk equation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.